Anders Jarneborn
Impact in
- Microbiology top 10%
- Antimicrobial Peptides and Activities
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Antimicrobial Resistance in Staphylococcus 9
- Immunology 10
- Immune Response and Inflammation 8
- Co-authors
- Tao Jin (18 shared papers)Manli Na (8 shared papers)Abukar Ali (10 shared papers)Majd Mohammad (12 shared papers)Zhicheng Hu (11 shared papers)Rille Pullerits (9 shared papers)Eric Carlström (1 shared paper)Inger Ekman (1 shared paper)
In The Last Decade
Anders Jarneborn
19 papers receiving 342 citations
Peers
Comparison fields: 5 of 74
- Microbiology 45
- Infectious Diseases 124
- Immunology 101
- Clinical Biochemistry 19
- Surgery 104
Countries citing papers authored by Anders Jarneborn
This map shows the geographic impact of Anders Jarneborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Jarneborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Jarneborn more than expected).
Fields of papers citing papers by Anders Jarneborn
This network shows the impact of papers produced by Anders Jarneborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Jarneborn. The network helps show where Anders Jarneborn may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Jarneborn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 51 | |
| 2 | 2015 | 36 | |
| 3 | 2016 | 34 | |
| 4 | 2019 | 31 | |
| 5 | 2015 | 27 | |
| 6 | 2020 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2017 | 24 | |
| 9 | 2020 | 23 | |
| 10 | 2021 | 19 | |
| 11 | 2023 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 10 | |
| 15 | 2023 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2025 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2022 | 1 |
About Anders Jarneborn
Anders Jarneborn is a scholar working on Infectious Diseases, Immunology, Molecular Biology, Surgery and Microbiology, having authored 19 papers that have together received 346 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (9 papers), Immune Response and Inflammation (8 papers), Orthopedic Infections and Treatments (5 papers), Bacterial biofilms and quorum sensing (3 papers), Antimicrobial Peptides and Activities (3 papers), Pharmacological Effects of Natural Compounds (2 papers), S100 Proteins and Annexins (2 papers) and Streptococcal Infections and Treatments (1 paper). The work is most often cited by research in Microbiology (45 citations), Infectious Diseases (124 citations), Immunology (101 citations), Clinical Biochemistry (19 citations) and Surgery (104 citations). Anders Jarneborn has collaborated with scholars based in Sweden, China and Germany. Frequent co-authors include Tao Jin, Manli Na, Abukar Ali, Majd Mohammad, Zhicheng Hu, Rille Pullerits, Eric Carlström, Inger Ekman, Lars‐Eric Olsson and Minh‐Thu Nguyen. Their work appears in journals such as The Journal of Infectious Diseases, Scientific Reports, Frontiers in Microbiology, Communications Biology and International Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.